688166 Brightgene Bio-Medical Technology Co.,Ltd.
- 23.00
- -0.94-3.93%
Brightgene Bio-Medical Technology Co.,Ltd. News
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on not revising the conversion price of “Borui Bonds” downwards
Announcement on voluntary disclosure of BGM0504 injection phase II clinical trial data for type 2 diabetes
Announcement Regarding Receipt of Notice of Acceptance of Civil Application for Retrial Case.
Announcement regarding the change of operation scope and the amendment of the "Company Charter"
Announcement regarding the election of the board of directors and the board of supervisors.
Notice for the expected satisfaction of the conversion price adjustment conditions for Borui convertible bonds.
Announcement of convertible bonds conversion results and share changes.
Announcement regarding the addition of new implementation entities for some funded projects.
Announcement regarding the debt-for-equity swaps conversion price adjustment for the 2023 annual equity distribution of convertible bonds.
Resolution of the 2023 Annual Shareholders Meeting.
Rating report on Borui Biomedical (Suzhou) Co., Ltd. and the "Borui Convertible Bonds" for the 2024 tracking year.
Announcement on Credit Rating Results Tracking of "Borui Convertible Bonds"
Notice on the suspension of the conversion of 'Borui Convertible Bonds' during the implementation of the 2023 annual equity distribution.
Borui Biomedical (Suzhou) Co., Ltd. entrusted the management of convertible corporate bonds issued to unspecified persons. Trustee Management Report (2023).
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on the 2023 Annual General Meeting of Shareholders of Borui Biopharmaceuticals (Suzhou) Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Notice on how securities regulators and exchanges have been penalized or taken regulatory measures in the last five years
Announcement on Yuan Jiandong's issuance of a letter of commitment on matters relating to the company's issuance of shares to specific targets in 2024
Analysis
Price Target
No Data
No Data